190 related articles for article (PubMed ID: 8175673)
21. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
Ueno T; Mitsuya H
Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
[TBL] [Abstract][Full Text] [Related]
22. Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.
Veal GJ; Wild MJ; Barry MG; Back DJ
Br J Clin Pharmacol; 1994 Oct; 38(4):323-8. PubMed ID: 7833221
[TBL] [Abstract][Full Text] [Related]
23. In vitro antiviral activity of didanosine compared with that of other dideoxynucleoside analogs against laboratory strains and clinical isolates of human immunodeficiency virus.
Hitchcock MJ
Clin Infect Dis; 1993 Feb; 16 Suppl 1():S16-21. PubMed ID: 8425017
[TBL] [Abstract][Full Text] [Related]
24. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Richman DD; Kornbluth RS; Carson DA
J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
[TBL] [Abstract][Full Text] [Related]
25. Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.
Balzarini J; Herdewijn P; De Clercq E
J Biol Chem; 1989 Apr; 264(11):6127-33. PubMed ID: 2539371
[TBL] [Abstract][Full Text] [Related]
26. Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2',3'-dideoxynucleosides.
Gao WY; Johns DG; Mitsuya H
Mol Pharmacol; 1994 Oct; 46(4):767-72. PubMed ID: 7969058
[TBL] [Abstract][Full Text] [Related]
27. Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.
Mathez D; Schinazi RF; Liotta DC; Leibowitch J
Antimicrob Agents Chemother; 1993 Oct; 37(10):2206-11. PubMed ID: 7504908
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the sensitivities of primary isolates of HIV type 2 and HIV type 1 to antiviral drugs and drug combinations.
Cox SW; Apéria K; Albert J; Wahren B
AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1725-9. PubMed ID: 7888232
[TBL] [Abstract][Full Text] [Related]
29. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS
Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712
[TBL] [Abstract][Full Text] [Related]
30. [What is known about the cellular and molecular pharmacodynamics of nucleosides?].
Sommadossi JP
Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):781-7. PubMed ID: 8309721
[TBL] [Abstract][Full Text] [Related]
31. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
[TBL] [Abstract][Full Text] [Related]
32. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
Shirasaka T; Yarchoan R; O'Brien MC; Husson RN; Anderson BD; Kojima E; Shimada T; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):562-6. PubMed ID: 8380641
[TBL] [Abstract][Full Text] [Related]
33. Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2'-beta-fluoro-2',3'-dideoxyadenosine in peripheral blood mononuclear cells.
Gao WY; Mitsuya H; Driscoll JS; Johns DG
Biochem Pharmacol; 1995 Jul; 50(2):274-6. PubMed ID: 7632173
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
[TBL] [Abstract][Full Text] [Related]
35. Sustainable Protocol for the Synthesis of 2',3'-Dideoxynucleoside and 2',3'-Didehydro-2',3'-dideoxynucleoside Derivatives.
Martín-Nieves V; Sanghvi YS; Fernández S; Ferrero M
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807233
[TBL] [Abstract][Full Text] [Related]
36. In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells.
Aoki-Sei S; O'Brien MC; Ford H; Fujii H; Gilbert DA; Cooney DA; Johns DG; Broder S; Mitsuya H
J Infect Dis; 1991 Nov; 164(5):843-51. PubMed ID: 1940465
[TBL] [Abstract][Full Text] [Related]
37. Structural analysis of 2',3'-dideoxyinosine, 2',3'-dideoxyadenosine, 2',3'-dideoxyguanosine and 2',3'-dideoxycytidine by 500-MHz 1H-NMR spectroscopy and ab-initio molecular orbital calculations.
Plavec J; Koole LH; Chattopadhyaya J
J Biochem Biophys Methods; 1992 Dec; 25(4):253-72. PubMed ID: 1337354
[TBL] [Abstract][Full Text] [Related]
38. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.
Lake-Bakaar G; Mazzoccoli V; Dickman K; Lyubsky S
Dig Dis Sci; 2001 Sep; 46(9):1853-63. PubMed ID: 11575436
[TBL] [Abstract][Full Text] [Related]
40. Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis.
Faraj A; Fowler DA; Bridges EG; Sommadossi JP
Antimicrob Agents Chemother; 1994 May; 38(5):924-30. PubMed ID: 7520683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
